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Background: Patients with diabetes mellitus (DM) are more susceptible to urinary tract infection (UTI) than non-diabetics.
Due to the emergence of multidrug resistant (MDR) uropathogenic strains, the choice of antimicrobial agent is restricted.
This study investigated the epidemiology of UTI, antimicrobial susceptibility, and resistance patterns of bacterial isolates
from adult diabetic patients.
Methods: A cross-sectional study was conducted at Khartoum Hospital, Sudan during the period of March − September
2013. Consecutive patients (men and women) were approached to participate in the study, irrespective of UTI symptoms.
Socio-demographic and clinical data were obtained from each participant using pre-tested questionnaires. Clean-catch,
midstream urine samples were collected and cultured for UTI diagnosis and antimicrobial susceptibility. Symptomatic
bacteriuria was defined as a positive urine culture (≥105 colony-forming units [CFU]/mL of a single bacterial species) from
patients with symptoms associated with UTI; asymptomatic bacteriuria was defined as a positive urine culture from
patients without symptoms associated with UTI.
Results: A total of 200 diabetic patients were enrolled, 121 (60.5%) men and 79 (39.5%) women; 193 (96.5%) had type II
DM. The overall prevalence of UTI was 39 (19.5%). Among the total population, 17.1% and 20.9% had symptomatic and
asymptomatic bacteriuria, respectively. According to multivariate logistic regression, none of the investigated factors (age,
sex, type of DM and duration) were associated with UTI. The predominant isolates were Escherichia coli (22, [56.4%]),
and Klebsiella pneumoniae, [9, (23%)]. Eight of 22 E. coli, four of nine K. pneumoniae and one of five Enterococcus faecalis
isolates originated from symptomatic patients. Six, four, three, and two of 22 E. coli isolates showed resistance to
ampicillin, co-trimoxazole, nitrofurantoin, and amoxicillin-clavulanic acid, respectively. Two, two, one and one of nine K.
pneumoniae isolates were resistant to ampicillin, co-trimoxazole, cephalexin, and amoxicillin-clavulanic acid. All 22 E. coli
isolates were sensitive (100%) to gentamicin and cephalexin. All nine K. pneumoniae were sensitive to gentamicin
(100%) and 88.8% were sensitive to cephalexin.
Conclusion: In Sudan, about one-fifth of diabetic patients have UTI. E. coli is the most frequent isolate followed by K.
pneumoniae.
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Diabetes mellitus (DM) is a worldwide health problem,
with an expected prevalence of 593 million by 2035 [1].
In Sudan, the prevalence of DM is 2.6%, including pa-
tients with poor glycemic control and about 67% with
long-term complications of DM [2,3]. Urinary tract in-
fection (UTI) is the most common infection among pa-
tients with DM and is responsible for considerable
morbidity, particularly if it is unrecognized or untreated
[4,5]. In Ethiopia, the rates of symptomatic and asymp-
tomatic bacteriuria among diabetic patients are an esti-
mated 13.6% and 10.4%, respectively [6]. Risk factors for
UTI among patients with and without DM have been
identified e.g. obesity, female sex, and prostate syndrome
in men [7,8]. Furthermore, glycosuria, low immunity,
and bladder dysfunction, which are associated with DM,
are considered particular risk factors for UTI [9,10].
Escherichia coli is the most commonly isolated organism
in both diabetic and non-diabetic patients [11,12].
The prevalence of DM is increasing worldwide and the
emergence of multi-drug-resistant (MDR) strains is escal-
ating; hence, determining the prevalence of UTI among
diabetic patients and investigating the sensitivity of bacter-
ial isolates to antimicrobial agents is important for the epi-
demiologist, scientist, health planner, and clinician. To the
best of our knowledge, there are no published data regard-
ing the epidemiology of UTI among diabetic patients in
Sudan. Thus, this study was conducted at the Khartoum
Hospital, Sudan, to provide epidemiological data about
UTI among diabetic patients in Sudan.Methods
A cross-sectional study was conducted at Khartoum
Hospital during the period March − September 2013.
The hospital, with a capacity of 208 beds, is the largest
governmental and referral hospital in the Sudanese cap-
ital of Khartoum, which receives referral cases from out-
side and within Khartoum state. Consecutive male and
female patients with type I or type II DM who attended
the referral clinic were approached to participate in the
study, regardless of the presence or absence of UTI
symptoms. Exclusion criteria included pregnancy, known
underlying renal pathology or chronic renal disease, or
use of antimicrobial therapy during the previous month.
After providing written informed consent, relevant clin-
ical and socio-demographic characteristics were col-
lected using pre-tested questionnaires. Every patient was
asked about symptoms suggestive of UTI (e.g., urgency,
dysuria, urinary frequency, loin pain, and nausea) and
history of other medical disorders, such as hypertension
and, for males, prostate enlargement. Each patient’s weight,
height, and body mass index (BMI) were calculated, and
hemoglobin and blood glucose were measured.Specimen collection and processing
Participants were asked to provide a midstream urine
sample according to the clean-catch procedure. Samples
were collected using a sterile container that was refriger-
ated (4°C), transported in an ice-pack to the medical la-
boratory, and processed within 1 hour of collection.
Using a standard quantitative loop, urine samples (1 μL
and 10 μL) were used to inoculate Cysteine lactose elec-
trolyte deficient (CLED) agar (Oxoid, Basingstoke, UK),
MacConkey, 5% Sheep Blood agar, and chromogenic
UTI (Oxoid) agar plates. Plates were incubated for 24 h
at 37°C and the outcome was judged as significant/non-
significant growth, or contaminated (discarded). Signifi-
cant bacteriuria was defined as urine culture plates
showing ≥105 colony-forming units (CFU)/mL of single
bacterial species. Symptomatic bacteriuria was defined
as significant bacteriuria in addition to symptoms related
to UTI, while asymptomatic bacteriuria was defined as
significant bacteriuria in the absence of UTI symptoms.
MDR bacteria were defined as isolates resistant to ≥2
antimicrobial agents.Identification of species and antimicrobial susceptibility
testing
Chromogenic culture plates were used for growth morph-
ology, then isolates were Gram-stained and species con-
firmed by in-house biochemical testing [13]. Gram-negative
organisms, e.g. E. coli, Klebsiella pneumonia, and Proteus
mirabilis, were distinguished by microscopy. E. coli was
identified as medium, pink-to-red colonies and confirmed
by positive indole test, whereas K. pneumonia were large,
pink-to-mauve colonies, which were confirmed by negative
oxidase and indole tests. P. mirabilis was assessed as small
pale-to-colorless colonies testing positive to indole and ure-
ase but negative to oxidase. Enterococcus faecalis was the
only Gram-positive microorganism that was isolated and
was identified by the presence of small, turquoise colonies
with coccoid morphology, which tested negative for cata-
lase and positive for bile esculin.
The disc diffusion method was used to determine the
antimicrobial susceptibility of isolates. Colonies were
suspended in normal saline to 0.5 McFarland standard,
and using disposable sterile swabs, the suspensions were
inoculated on Muller-Hinton agar (Oxoid) and incu-
bated for 18–24 h, according to Clinical and Laboratory
Standards Institute (CLSI) guidelines [14]. E. coli ATCC®
25922 and E. faecalis ATCC® 29212 were used as control
strains. Antimicrobial susceptibility and resistance was
determined by isolate growth zone diameter according
to CLSI guidelines as shown in Table 1. All antibiotic
discs were from Oxoid. Amoxicillin-clavulanic acid was
prescribed for symptomatic patients as empirical treat-
ment before culture results were obtained. All patients
Table 1 Antimicrobial specific disc content and inhibitory
zone diameter tested against Enterobacteriaceae and
Enterococcus faecalis bacteria
Organism/antimicrobial Disk content Zone diameter
Enterobacteriaceae R S
Ampicillin 10 μg ≥17 mm ≤13 mm
Gentamicin 10 μg ≥15 mm ≤12 mm
amoxicillin-clavulanic acid 20 μg/10 μg ≥18 mm ≤13 mm
Cephalexin 30 μg ≥18 mm ≤14 mm
co-trimoxazole 1.25/23.75 μg ≥16 mm ≤10 mm
Nitrofurantoin 300 μg ≥17 mm ≤14 mm
E. faecalis
Ampicillin 10 μg ≥17 mm ≤13 mm
amoxicillin-clavulanic acid 20 μg/10 μg ≥18 mm ≤13 mm
Nitrofurantoin 300 μg ≥17 mm ≤14 mm
Ciprofloxacin 5 μg ≥21 mm ≤15 mm
Enterobacteriaceae include; E. coli, K. pneumoniae, P. mirabilis.
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2 days and their treatment was evaluated.
Statistical analysis
Data were entered into the computer using Statistical
Package for the Social Sciences software for Windows
version 16.0 (SPSS Inc., Chicago, IL, USA) and double-
checked before analysis. Means and proportions of the
socio-demographic and clinical characteristics were cal-
culated and compared between the culture-positive
and -negative groups using student t and X2 tests, re-
spectively. Univariate and multivariate analyses were used
for the culture-positive group as dependent variables, and
socio-demographic (age, sex and BMI) and clinical (dur-
ation of DM, type of DM, history of UTI, dysuria, urgency,Table 2 Clinical characteristics of patients and factors associa
and multivariate analyses
Variables Patients with Bacteriuria Patients witho
n = 39 n = 161
Age, years 58.6(9.9)* 57.9(11.6)*
Male sex 27(69.2)# 94(58.3) #
Body mass index, kg/m2 25.4(6.1)* 25.9(5.8)*
Duration of diabetes, years 16.7(11.7)* 14.4(8.5)*
Type II diabetes 35(89.7) # 158(98.1) #
History of UTI 5(12.8) # 18(11.1) #
Hemoglobin, g/dl 13.4(1.0)* 13.4(1.5)*
Blood glucose level, mg/dl 174.1(54.2)* 161 (42.1)*
Dysuria 13(33.3) # 63(39.1) #
Urgency 6(15.3) # 11(6.8) #
Data were shown as mean (SD) * or n (%) # as applicable. Abbreviations: OR, Odds
analyses were added to multivariate analysis.hemoglobin and blood glucose levels) variables as inde-
pendent parameters. Probability values of <0.05 were con-
sidered as statistically significant for all results.
Results
Two hundred patients with DM were recruited; seven
(3.5%) had type I and 193 (96.5%) had type II DM. There
were more males than females, 121 (60.5%) vs. 79
(39.5%). Among the 200 diabetic patients, 76 (38%) had
symptoms suggestive of UTI. The overall prevalence of
UTI was 19.5%.
The prevalence of bacteriuria among symptomatic and
asymptomatic diabetic patients was 17.1% and 20.9%, re-
spectively, with no significant between-group difference.
Compared with 22.3% of males, only 15.1% of females
had bacteriuria (P = 0.043). Mean ages (SD) of the bac-
teriuric and non-bacteriuric patients were 58.6 (9.9) and
57.9 (11.6) years, respectively, (P = 0.981). There was no
significant difference in the socio-demographic and clin-
ical data between bacteriuric and non-bacteriuric dia-
betic patients (Table 2).
Risk factors for urinary tract infections
Using logistic regression, although univariate analysis
showed an association between type of DM and UTI,
multivariate analysis showed no association between
type of DM and other investigated factors (age, sex, type
of DM, duration of DM, symptoms and BMI) and UTI
(Table 2).
Bacterial isolates and susceptibility to antimicrobials
Thirty-four (87.1%) and 5 (12.8%) of the 39 isolates were
Gram-negative and -positive bacteria, respectively. The pre-
dominant organism isolated was E. coli (22 isolates, 56.4%).ted with UTI among diabetic patients using univariate
ut Bacteriuria Univariate analysis Multivariate analysis
OR 95% CI P OR 95% CI P
1.0 0.9-1.0 0.641 1.0 0.9-1.0 0.548
1.6 0.7-1.9 0.216 1.4 0.5-3.3 0.452
0.9 0.8-1.1 0.771 0.9 0.8-1.03 0.291
1.0 0.9-1.1 0.412 1.0 0.9-1.0 0.422
6.0 1.2-28.1 0.022 4.3 0.6-27.5 0.121
1.1 0.4-3.3 0.773 1.2 0.3-3.8 0.721
1.0 0.5-1.7 0.905 0.9 0.9-1.0 0.501
1.0 0.9-1.0 0.433 0.9 0.9-1.0 0.248
0.7 0.3-1.6 0.504 0.7 0.3-1.6 0.448
2.4 0.1-13.8 0.094 1.5 0.4-6.1 0.497
Ratio; CI, confidence interval; P, probability value. All variables in the univariate
Table 3 Antimicrobial susceptibility pattern of Gram-negative and Gram-positive bacteria isolated from diabetic
patients
Isolates RXN Antimicrobial agents (%)
AP CN A-C CEX SXT NF CIPGram-negative
E. coli (n = 22) S 16 (72.7) 22 (100) 20 (90.9) 22 (100) 18 (81.8) 19 (86.3) Nt
R 6 (27.2) - 2 (9) - 4 (18.1) 3 (13.6) Nt
K. pneumonia (n = 9) S 7 (77.7) 9 (100) 8 (88.8) 8 (88.8) 7 (77.7) 9 (100) Nt
R 2 (22.2) - 1 (11.1) 1 (11.1) 2 (22.2) - Nt
P. mirabilis (n = 3) S 2 (66.6) 3 (100) 3 (100) 3 (100) 2 (66.6) 2 (66.6) Nt
R 1 (33.3) - - - 1 (33.3) 1 (33.3) Nt
Total (n = 34) S 25 (73.5) 34 (100) 31 (91.1) 33 (97) 27 (79.4) 30 (88.2) Nt
R 9 (26.4) - 3 (8.8) 1 (2.9) 7 (20.5) 4 (11.7) Nt
Gram-positive
E.faecalis (n = 5) S 4(80) Nt 5(100) Nt Nt 5(100) 4(80)
R 1(20) Nt - Nt Nt - 1(20)
Key: S, Sensitive; R, Resistant; −, zero; Nt, Not tested; AP, ampicillin; CN, gentamicin; A-C, amoxicillin-clavulanic acid; CEX, cephalexin; SXT, co-trimoxazole; NF,
nitrofurantoin; CIP, ciprofloxacin.
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(5, 12.8%), and P. mirabilis (3, 7.6%).Antimicrobial susceptibility pattern of bacterial isolates
Gram-negative bacteria
Gram-negative bacteria (E. coli, K. pneumoniae and P.
mirabilis) were tested against six antimicrobial agents:
ampicillin, gentamicin, amoxicillin-clavulanic acid, ceph-
alexin, co-trimoxazole, and nitrofurantoin. All isolates
(100%) were susceptible to gentamicin. E. coli (the pre-
dominant isolate) and P. mirabilis were 100% susceptible
to cephalexin. Moreover, 8 out of the 9K. pneumonia
isolates were susceptible to cephalexin (Table 3).Table 4 Figure of bacteria resistance to two, three and
four antimicrobial agents
Antibiogram
No. (%) of resistanceGram-positive bacteria
E. faecalis (n = 5) were the only Gram-positive bacteria
isolated in this study. As assessed against four antimicro-
bial agents, ampicillin, amoxicillin-clavulanic acid, nitro-
furantoin, and ciprofloxacin, E. faecalis isolates were
100% susceptible to amoxicillin-clavulanic acid and
nitrofurantoin. Only 20% of the E. faecalis isolates were
resistant to ampicillin and ciprofloxacin (Table 3).Organism R2 R3 R4
Gram-negative
E. coli (n = 22) 3 (13.6) 1 (4.5) 1 (4.5)
K. pneumonia (n = 9) 2 (22.2) - 1 (11.1)
P. mirabilis (n = 3) - 1 (33.3) -
Total (n = 34) 5 (14.7) 2 (5.8) 2 (5.8)
Gram-positive
E. faecalis(n = 5) 1 (20) - -
R2–R4 = number of antimicrobial agents to which a given isolate was resistant.Multi-drug-resistance patterns of the isolates
Multi-drug-resistance was observed in 11 (28.2%) of the
total 39 isolates. Twenty-three percent (5/22) of the E. coli
isolates showed multi-drug-resistance against two to four
antimicrobial agents (Table 3). Twenty percent (1/5) of
the E. faecalis isolates (the only Gram-positive bacteria),
showed multi-drug-resistance against two antimicrobial
agents (Table 4).Discussion
The main findings of the present study were that the
prevalence of symptomatic, asymptomatic, and overall
bacteriuria among diabetic patients was 17.1%, 20.9%,
and 19.5%, respectively. E. coli was the most common
organism isolated. The reported prevalence of symptom-
atic and asymptomatic bacteriuria in this study was
higher than the 13.6% and 10.4% reported in Ethiopia, a
neighboring country [6]. Sudanese diabetic patients have
poor glycemic control, which may explain the high
prevalence of UTI in this setting [2]. Poor control of
DM increases the risk of UTI by 24% [15]. Generally,
compared with non-diabetic patients, diabetic patients
have a higher incidence of UTI and asymptomatic bac-
teriuria [16,17]. However, we found that the prevalence
of symptomatic and asymptomatic bacteriuria among
pregnant women in our previous work was 12.1% and
14.7% respectively [12]. It is worth mentioning that in
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105 CFU/mL regardless of patients’ symptoms. If a lower
bacterial count, such as 103 CFU/mL associated with pa-
tients’ symptoms had been used, then a higher percent-
age of symptomatic and asymptomatic bacteriuria would
have been obtained.
In the current study, none of the investigated factors
(patient age, duration and type of DM) were associated
with the prevalence of UTI. Similar findings were re-
ported for diabetic patients in Saudi Arabia [7]. Previous
studies have shown that older age, duration of DM, and
level of DM control are risk factors for UTI among dia-
betic patients [4,18]. Likewise, BMI, history of UTI, and
sexual intercourse have been reported as independent
risk factors for UTI among diabetic patients [7,19,20]. In
this study, in line with one previous report [7], no asso-
ciation between duration of DM and UTI was observed.
Diabetic patients are at increased risk of infection in
general and, in particular, to UTI [21]. The susceptibility
of diabetic patients to UTI could be explained by dimin-
ished neutrophil response, lower urinary cytokines, and
leukocyte concentrations, which might facilitate the adhe-
sion of microorganisms to uroepithelial cells [16,22,23].
Interestingly, sexual intercourse was reported as a risk fac-
tor for UTI in women regardless of their DM status
[24,25]. It is difficult to investigate sexual practice in this
setting (due to cultural and traditional regulations); if this
had been investigated, perhaps different results might have
been obtained.
In this study, 63 (39.1%) patients had dysuria without
bacteriuria. Other diseases, such as tuberculosis and
sexually transmitted diseases (STDs), which were not in-
vestigated in this study, could explain the dysuria with-
out bacteriuria. The current study showed that E. coli
was the most common organism isolated from both
symptomatic and asymptomatic patients, and it was re-
sistant mainly to ampicillin, co-trimoxazole, nitrofuran-
toin, and amoxicillin-clavulanic acid. This is in line with
reports from Ethiopia, Libya, and Kenya [6,11,26]. Fur-
thermore, this is in agreement with a recent report from
Ethiopia, where over 60% of the isolated urinary E. coli
was resistant to ampicillin [6]. Emergence of uropatho-
genic MDR E. coli was previously reported among preg-
nant women in the same region [12]. However, increasing
evidence shows an increase in strains of MDR E. coli in
diabetic and non-diabetic [27,28]. Niranjan and Malini
claim that DM per se is a risk factor for infection by MDR
E. coli [29]. This report is contradicted by other studies
[30,31]. In our study, there was no association between
DM and the development of UTI, and the number of
MDR E. coli strains was small. Patients’ geographical re-
gion, lifestyle and health care factors may possibly be re-
lated to MDR E. coli [32]. K. pneumoniae was the second
most commonly isolated organism, which is in agreementwith a recent report from Nepal [33]. However, this order
of isolated microorganisms does not differ from that re-
ported in non-diabetic patients [34].
Conclusion
About one-fifth of diabetic patients had UTI in our
study. In both symptomatic and asymptomatic diabetic
patients with UTI in Sudan, E. coli was the most fre-
quent isolate followed by K. pneumoniae. Multi-drug re-
sistance was observed in 28.2% of the total isolates.
Ninety-seven percent of the Gram-negative bacteria
were sensitive to cephalexin, while all Gram-negative or-
ganisms showed 100% sensitivity to gentamicin.
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